Characterization and Management of Cytokine Release Syndrome From the <scp>MonumenTAL</scp> ‐1 Study of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma
Characterization and Management of Cytokine Release Syndrome From the MonumenTAL ‐1 Study of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma
Sheri Skerget, Ajai Chari, Brandi Hilder, Thomas Renaud et al.
Citations
1 citations
Journal
Cancer Medicine
Topics
CAR-T cell therapy research
Field-Weighted Citation Impact (FWCI)
1.05
article
Characterization and Management of Cytokine Release Syndrome From the MonumenTAL ‐1 Study of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma
Sheri Skerget, Ajai Chari, Brandi Hilder, Thomas Renaud, Leo Rasche, Tara Masterson, María‐Victoria Mateos, Niels W.C.J. van de Donk, Cesar Rodriguez, Jaszianne Tolbert, Jing Christine Ye, Carolina Schinke, Deeksha Vishwamitra, Amrita Krishnan, Raluca Verona, Rakesh Popat, Christoph Heuck, Brea Lipe, Indrajeet Singh, Michela Campagna, Jue Gong, M. Damiette Smit, Thomas G. Martin
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Cancer MedicineVol. 14(19)
Institutions
Johnson & Johnson (United States) (US), University College London Hospitals NHS Foundation Trust (GB), The University of Texas MD Anderson Cancer Center (US), University of California, San Francisco (US), Universidad de Salamanca (ES), University of Rochester Medical Center (US), City of Hope (US), Universitätsklinikum Würzburg (DE), Instituto de Investigación Biomédica de Salamanca (ES), Johnson & Johnson (Israel) (IL), Centro de Investigación del Cáncer (ES), Amsterdam University Medical Centers (NL), Johnson & Johnson (Netherlands) (NL), Centro de Investigación Biomédica en Red de Cáncer (ES), Johnson & Johnson (Brazil) (BR), UCSF Helen Diller Family Comprehensive Cancer Center (US), University College London (GB), Wake Forest University (US), University of Arkansas for Medical Sciences (US), Vrije Universiteit Amsterdam (NL)